LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...
LA JOLLA, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...
StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the biopharmaceutical companys...
StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV Free Report) in a research report released on Tuesday. The firm issued a hold rating on the biopharmaceutical...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
LA JOLLA, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...
StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV Free Report) in a research report report published on Saturday morning. The brokerage issued a hold rating on the...
Equities research analysts at StockNews.com started coverage on shares of MediciNova (NASDAQ:MNOV Get Free Report) in a report issued on Tuesday. The firm set a hold rating on...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
LA JOLLA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...